Immunotherapy highlights from the 2011 meeting of the American Society of Hematology

References

• Heslop HE, Slobod KS, Pule MA et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115, 925–935 (2010).
   PubMed Web of Science ®Google Scholar
• Savoldo B, Ramos CA, Liu E et al. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J. Clin. Invest. 121, 1822–1826 (2011).
   PubMed Web of Science ®Google Scholar
• Marr LA, Gilham DE, Campbell JD, Fraser AR. Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies. Clin. Exp. Immunol. 167, 216–225 (2012).
   PubMed Web of Science ®Google Scholar
• Hasan A, Bakalar D, Selvakumar A et al. CMV-specific T cells are more effective than WT-1-specific T cells in eradicating clonogenic tumor cells co-expressing CMV pp65 and WT-1 in vivo and both types of T cells are functionally augmented in the presence of IL-15/IL-15Rα. Blood 118, 646 (2011) (Abstract).
   Google Scholar
• Gerdemann U, Katari U, Christin AS et al. Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma. Mol. Ther. 19, 2258–2268 (2011).
   PubMed Web of Science ®Google Scholar
• Hudecek M, Lupo-Stanghellini M, Kosasih P et al. Naive CD4+ T cells modified to express a ROR1-specific CAR mediate anti-tumor activity and provide superior help to CD8+ ROR1-CAR T cells. Blood 118, 643 (2011) (Abstract).
   Google Scholar
• Hinrichs CS, Borman ZA, Cassard L et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior anti-tumor immunity. Proc. Natl Acad. Sci. USA 106, 17469–17474 (2009).
   PubMed Web of Science ®Google Scholar
• Berger C, Jensen MC, Lansdorp PM et al. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118, 294–305 (2008).
   PubMed Web of Science ®Google Scholar
• Ochi T, Fujiwara H, Okamoto S et al. Redirected CD4+ T cells using WT1-specific T-cell receptor gene transfer can supply multifactorial help to enhance the anti-leukemia reactivity mediated by similarly redirected CD8+ T cells using the identical gene transfer. Blood 118, 645 (2011) (Abstract).
   Google Scholar
• Provasi E, Genovese P, Lombardo A et al. TCR gene editing results in effective immunotherapy of leukemia without the development of GvHD. Blood 118, 667 (2012) (Abstract).
   Google Scholar
• Schwarzenberg L, Mathe G, Schneider M et al. Attempted adoptive immunotherapy of acute leukaemia by leucocyte transfusions. Lancet 2, 365–368 (1966).
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Storb R, Buckner CD et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N. Engl. J. Med. 320, 828–834 (1989).
   PubMed Web of Science ®Google Scholar
• Ghosh A, Dogan Y, Holland A et al. Over-expression of TRAIL on donor T cells enhances GVT and suppresses GVHD via elimination of alloreactive T cells and host APC. Blood 118, 817 (2011) (Abstract).
   Google Scholar
• Stevanovic S, van Schie M, Griffioen M, Falkenburg J. HLA Class II disparity is necessary and sufficient for induction of effective anti-tumor immunity by donor lymphocyte infusion in a NOD/SCID mouse model for human acute lymphoblastic leukemia. Blood 118, 648 (2011) (Abstract).
   Google Scholar
• Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 9, 111–122 (2007).
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Cruz CR, Savoldo B et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood 114, 1958–1967 (2009).
   PubMed Web of Science ®Google Scholar
• Hanley P, Martinez C, Leung K et al. Phase I study to improve virus-specific immune reconstitution after cord blood transplantation using cord blood-derived virus-specific cytotoxic T lymphocytes. Blood 118, 155 (2011) (Abstract).
   Google Scholar
• Reger R, Berg M, Lundqvist A et al. A Phase I trial of adoptively transferred ex-vivo expanded autologous natural killer (NK) cells following treatment with bortezomib to sensitize tumors to NK cell cytotoxicity. Blood 118, 654 (2011) (Abstract).
   Google Scholar
• Okamoto S, Mineno J, Ikeda H et al. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Cancer Res. 69, 9003–9011 (2009).
   PubMed Web of Science ®Google Scholar
• Leen AM, Rooney CM, Foster AE. Improving T cell therapy for cancer. Annu. Rev. Immunol. 25, 243–265 (2007).
   PubMed Web of Science ®Google Scholar
• Dudley ME, Wunderlich JR, Yang JC et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346–2357 (2005).
   PubMed Web of Science ®Google Scholar
• Di Stasi A, Tey SK, Dotti G et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N. Engl. J. Med. 365, 1673–1683 (2011).
   PubMed Web of Science ®Google Scholar
• Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin. Immunol. 127, 286–297 (2008).
   PubMed Web of Science ®Google Scholar
• Gadri Z, Kukulansky T, Bar-Or E, Haimovich J, Hollander N. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma. J. Immunother. 32, 333–340 (2009).
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Calzascia T, Elford AR et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat. Med. 15, 528–536 (2009).
   PubMed Web of Science ®Google Scholar